Shanghai Kaibao Pharmaceutical Free Cash Flow Generation Index
Shanghai Kaibao Pharmaceutical free cash flow generation index. Shanghai Kaibao Pharmaceutical (300039) has a Free Cash Flow Generation Index of 0.98x as of September 2025. Free cash flow of CN¥187.61 Million represents 1% of operating cash flow (CN¥190.98 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Shanghai Kaibao Pharmaceutical (2006–2025)
Free cash flow generation index of Shanghai Kaibao Pharmaceutical from 2006 to 2025. Historical FCF Generation Index trend for Shanghai Kaibao Pharmaceutical across 20 annual periods. See 300039 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Shanghai Kaibao Pharmaceutical Free Cash Flow Generation Index by Year (2006–2025)
Shanghai Kaibao Pharmaceutical free cash flow generation index by year from 2006 to 2025. Year-by-year Free Cash Flow Generation Index for Shanghai Kaibao Pharmaceutical. For the full cash flow conversion analysis, see Shanghai Kaibao Pharmaceutical cash conversion from operations.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.88x | CN¥203.70 Million | CN¥230.74 Million | CN¥27.04 Million | ▲ +77.9% |
| 2024 | 0.50x | CN¥138.43 Million | CN¥278.95 Million | CN¥140.52 Million | ▼ -46.3% |
| 2023 | 0.92x | CN¥353.59 Million | CN¥382.66 Million | CN¥29.08 Million | ▲ +0.9% |
| 2022 | 0.92x | CN¥344.80 Million | CN¥376.42 Million | CN¥31.62 Million | ▲ +38.3% |
| 2021 | 0.66x | CN¥83.53 Million | CN¥126.08 Million | CN¥42.55 Million | ▼ -29.8% |
| 2020 | 0.94x | CN¥236.71 Million | CN¥250.65 Million | CN¥13.94 Million | ▼ -1.0% |
| 2019 | 0.95x | CN¥318.63 Million | CN¥334.09 Million | CN¥15.46 Million | ▲ +5.9% |
| 2018 | 0.90x | CN¥236.29 Million | CN¥262.36 Million | CN¥26.07 Million | ▲ +12.6% |
| 2017 | 0.80x | CN¥196.51 Million | CN¥245.76 Million | CN¥49.24 Million | ▼ -12.5% |
| 2016 | 0.91x | CN¥287.85 Million | CN¥314.88 Million | CN¥27.03 Million | ▲ +8.1% |
| 2015 | 0.85x | CN¥276.68 Million | CN¥327.08 Million | CN¥50.40 Million | ▲ +11.8% |
| 2014 | 0.76x | CN¥213.64 Million | CN¥282.38 Million | CN¥68.74 Million | ▲ +34.6% |
| 2013 | 0.56x | CN¥151.95 Million | CN¥270.23 Million | CN¥118.28 Million | ▼ -28.4% |
| 2012 | 0.79x | CN¥191.12 Million | CN¥243.32 Million | CN¥52.21 Million | ▲ +162.1% |
| 2011 | 0.30x | CN¥29.46 Million | CN¥98.31 Million | CN¥68.85 Million | ▲ +119.0% |
| 2010 | -1.58x | CN¥-31.22 Million | CN¥19.79 Million | CN¥51.01 Million | ▼ -14.0% |
| 2009 | -1.38x | CN¥-72.97 Million | CN¥52.74 Million | CN¥125.70 Million | ▼ -449.0% |
| 2008 | 0.40x | CN¥7.41 Million | CN¥18.70 Million | CN¥11.28 Million | ▼ -50.5% |
| 2007 | 0.80x | CN¥18.65 Million | CN¥23.27 Million | CN¥4.62 Million | ▲ +98.3% |
| 2006 | 0.40x | CN¥7.96 Million | CN¥19.70 Million | CN¥11.74 Million | — |